PRECISEDAPTSCORE

The PRECISE-DAPT Risk Calculator was developed to predict the risk of bleeding in individual patients with coronary artery disease, treated coronary stenting and subsequent dual antiplatelet therapy (i.e. aspirin plus a P2Y12 receptor inhibitor). The score has been developed from a collaborative dataset including 14,963 patients from 8 randomized clinical trials, enrolled in more than 130 clinical sites and 12 countries worldwide. The PRECISE-DAPT Risk Score has been externally validated in two independent datasets. Data analysis, derivation and validation of the PRECISE-DAPT score were performed at the Erasmus Medical Center public health department (Rotterdam, The Netherlands). Statistical support and data for validation were provided by the Uppsala Clinical Research Center (Uppsala, Sweden) and the Department of Clinical Research, Clinical Trials Unit, University of Bern (Bern, Switzerland). No external funding were used for this analysis... About precisedaptscore